Crossmark

Bevacizumab regulates inflammatory cytokines and inhibits VEGFR2 signaling pathway in an ovalbumin-induced rat model of airway hypersensitivity

Published Online: 2021-03-19

Published Print: 2021-06

Authors

Bolandi, Seyed Mohammadreza

Abdolmaleki, Zohreh https://orcid.org/0000-0003-2016-5753
Assarehzadegan, Mohammad-Ali
License Information

Text and Data Mining valid from 2021-03-19

Version of Record valid from 2021-03-19
More Information

Article History

Received: 17 November 2020

Accepted: 6 March 2021

First Online: 19 March 2021

Declarations

:

: The authors declare that they have no conflict of interest.

Document is current